International FootballOn Buys Mbappé With Equity: The Deal Without an Invoice
International Football

On Buys Mbappé With Equity: The Deal Without an Invoice

**Core answer**: On Holding AG công bố hợp tác với Kylian Mbappé theo cấu trúc tiền mặt cộng cổ phần. Giá trị hợp đồng không được tiết lộ. Đây là bản sao khuôn mẫu Roger Federer, người nhận khoảng 2,5% cổ phần năm 2019. ROI chưa thể xác minh vì thiếu mẫu số. **Key facts**: - On Holding AG ký Kylian Mbappé theo cấu trúc tiền mặt và cổ phần; giá trị không công bố - Roger Federer nhận khoảng 2,5% cổ phần khi rời Nike về On năm 2019, theo Forbes - Cổ phiếu On giao dịch P/E 18,7 lần, cao hơn chút so với đối thủ đồ thể thao - Hơn 50% doanh thu On đến từ châu Mỹ, khu vực được báo cáo là suy yếu - M Science: On giành thị phần ba tháng đến tháng Tám; Nike tiếp tục mất thị phần **Source attribution**: Reuters, dẫn dữ liệu LSEG, M Science và Forbes | Cross-checked: VuaBong.vn **Related Q&A**: Q: On trả Mbappé bằng gì? A: Tiền mặt cộng cổ phần; tỷ lệ và giá trị không được tiết lộ. Q: Thương vụ có đáng tiền không? A: Không thể xác định vì On giữ kín giá trị hợp đồng. Q: Điều gì cần theo dõi tiếp? A: Doanh thu giày bóng đá quý tới, hiệu suất châu Mỹ và bất kỳ công bố pha loãng nào.

The day the press release left On Holding AG's communications office, the company's share price slipped 0.3% in a choppy session. Nobody called it a sell-off. But a deal attached to Kylian Mbappé, the most expensive star on the planet, that fails to lift the price is itself the data point. On disclosed no contract value: no term, no cash figure, no equity percentage for Mbappé. Only one line confirming structure, cash plus equity. The rest stayed quiet.

Three years after the signing ceremony, the secret clause still sits undisturbed in the financial basement. This time the basement belongs not to a football club. It belongs to a listed Swiss company, and the person opening the door is not a sporting director but an investor wondering how much was paid for an image.

On Holding AG is not a club. It is a Swiss sportswear firm, listed on the exchange, risen on running shoes with CloudTec cushioning. Revenue is concentrated in running and the North American market. When it announced Mbappé, this was no transfer, no release fee, no sell-on clause, no wage bill. It is an endorsement deal, and how it is structured is the real story.

To read the deal, I set it beside an older marker. In 2026, when Roger Federer left Nike for On, he received roughly 2.5% equity, according to Forbes. That is the template. On does not buy athletes with pure salary; it attaches a name to shareholder status, turning the endorser into a keeper of the books. When Mbappé arrived, the cash-plus-equity structure was not innovation. It was a copy of a running formula.

Alongside Mbappé came another appointment: Thierry Henry as director of the soccer business. A legend in an executive seat is not there to run a single ad campaign. It signals building football capability at the organisational level. But signing a big name does not by itself create a boot-development system, an athlete scouting network, or grassroots football infrastructure.

On's strategy is stacking adjacent categories: running, then tennis with Federer, then soccer with Mbappé. Each new category raises the marketing-cost bar. And soccer is the hardest step, because the rival here is not a young brand. It is Nike, which has sat atop the football boot industry for decades, with performance-validated sponsorship contracts on the pitch.

I keep a long-running dataset on cash flows across sportswear brands. My experience is this: the loudest announcements tend to carry the fewest numbers. When someone does not name a price, they usually have a reason not to.

The first thing I do with any equity-linked deal is split the number into three layers. Layer one is the nominal cash value. Layer two is the equity value at signing. Layer three is the real value when the equity vests, dependent on the future share price. On confirmed only layers one and two. Layer three, the one that decides everything, was not mentioned.

I count every line in the petition. Numbers never lie. But numbers do not surface while the door is locked. The only door left ajar here is structure: a blend of cash and equity. That is a meaningful financial choice, equity preserves cash in the short term but dilutes existing ownership, while tying the athlete to share performance. The endorser no longer simply takes cash. He sits on the same boat as the share price.

According to LSEG data cited by Reuters, On trades around 18.7x earnings, slightly above sportswear rivals. The number says one thing: the market has priced On as a high-growth company, and a Mbappé deal only means something if it feeds that growth story. Rising marketing costs with uncertain margins is a recipe for pressure.

The bright spot sits in M Science data: On gained market share in the three months to August, while Nike kept losing it. That is real momentum, not marketing. But there is a structural paradox rarely noted: more than 50% of On's revenue comes from the Americas, the very region the article flags as weakening. That means the Mbappé deal, if it works, must lift the weakest market. If it only lifts European image, where Mbappé is already famous, the investment hits an already saturated spot.

My experience of watching matches teaches one simple thing: never judge a player on one touch, and never judge a deal on one press release. My three verification layers, original documents, independent witnesses, cross-data from at least two systems, cannot be fully applied here, because On keeps most documents sealed. That very absence is the point.

I look at the sponsorship structure as a balance sheet missing its right column. The deal discloses partial cost and expects full benefit. There is no way to compute ROI when the denominator is hidden. And when the denominator is hidden, every claim about whether it is worth the money is speculation, from supporters and critics alike.

Three market voices point the same way. Morningstar's David Swartz asks the direct question: is the deal worth the cost. Jefferies' Randy Konik is more skeptical: performance credibility cannot be bought. And professional investors at Columbia Threadneedle view this as a capital-allocation decision, not a sporting event. This is an economics problem, not an image problem.

Cash-plus-equity structure is a spreading trend. From Federer to Mbappé, brands are paying stars partly in company stock, blurring the line between endorser and shareholder. This is not an On-only matter. It is a capital transmission mechanism: from sportswear marketing budgets into the athlete and agent ecosystem, then downstream into derivative markets such as boots, merchandise and video-game licensing.

But that flow has a chokepoint. If On succeeds, it may push up the price of top footballer endorsement deals industry-wide, a cost race. If On fails, it leaves a bad precedent: equity exchanged for image, but not for category position. Both scenarios matter to the rest of the industry, not just On.

At the governance level, the deal raises a rarely voiced question: when a listed company pays partly in equity, how it accounts for and values that equity package will be scrutinised. This is not a violation. It is a grey zone of standards, where numbers can be presented in more than one way, and where professional investors will read far more carefully than the cash portion.

The macro backdrop does not help. Consumers face inflation and an uncertain economy, the headwind the article itself names. In that environment, an expensive deal aimed at a new category must prove itself faster than usual, because both investors and shoppers are more cautious.

On the communications side, the story is passing through the hype phase. A famous endorsement generates coverage, while the counter-narrative about whether it is worth the cost forms in parallel. This is a pattern I have seen many times: hype first, doubt later, and if results lag, the reversal will be fiercer than the original enthusiasm.

There is a counter-intuitive argument I must place on the table: a top star does not automatically buy performance credibility. On has a manufacturing edge in LightSpray, currently used in running shoes. But transferring that technology from a running-shoe upper to a football boot is unproven: boots must withstand kicking loads, wet-grass traction and entirely different biomechanics. Under Armour once signed Stephen Curry and still did not topple Nike. The cautionary tale already has a name.

But the popular reading of the 0.3% dip reads far too much into a noisy data point. A single day's move is not a verdict. The market's real response will sit in next quarter's report, when soccer boot revenue appears, or does not. And the most overlooked part remains the equity package. If On pays Mbappé with conditional equity, the true cost is pushed into the future as dilution and commitments. In the short term, the deal looks light. In the long term, the invoice is still being written, its final figure simply not yet revealed.

What to track is very concrete: soccer boot revenue in next quarter's report, Americas regional performance, how Nike responds to defend its roster, and any dilution disclosure from the equity package. This deal has not yet won or lost. It has only begun to accumulate data.

The stands are empty, but the owners' accounting room has never lacked someone tapping numbers. There is no match of this deal on the pitch. But in the basement, the machine is still being punched.

Cầu thủ liên quan